Advertisement

Drugs Affecting Lipid Metabolism VIII

  • David Kritchevsky
  • William L. Holmes
  • Rodolfo Paoletti

Table of contents

  1. Front Matter
    Pages i-xiii
  2. Cellular Biology of Atherosclerosis

    1. W. A. Scott, N. A. Pawlowski, E. B. Cramer, Z. A. Cohn
      Pages 17-25
    2. H. Bryan Brewer Jr., Dennis L. Sprecher, Richard E. Gregg, Jeffrey M. Hoeg
      Pages 27-36
    3. S. H. Gianturco, A. M. Gotto Jr., W. A. Bradley
      Pages 47-71
  3. Apolipoprotein

    1. Henry J. Pownall, Antonio M. Gotto Jr.
      Pages 85-97
    2. Giancarlo Ghiselli, Bette C. Sherrill
      Pages 113-120
    3. John J. Albers
      Pages 125-133
    4. Gustav Schonfeld, Matti J. Tikkanen, Kyung-soo Hahm
      Pages 135-157
    5. K. H. Weisgraber, T. L. Innerarity, S. C. Rall Jr., R. W. Mahley
      Pages 159-171
  4. Noninvasive Assessment of Atherosclerosis

    1. M. Gene Bond, Sharon K. Wilmoth, Jean F. Gardin, Ralph W. Barnes, Janet K. Sawyer
      Pages 189-195
  5. Drugs and Diet

  6. Drugs and Diet

    1. David Kritchevsky, William L. Holmes, Rodolfo Paoletti
      Pages 371-480
  7. Back Matter
    Pages 499-502

About this book

Introduction

The Proceedings of the Eight International Symposium on Drugs Affecting Lipid Metabolism (8th D.A.L.M.) is the subject of this volume. Since the first symposium in 1960, each successive meeting has broken new ground in the field of pharmacological control of lipid levels - offering new and stimulating insights and exposing the audience to the state of the art. The field has progressed sufficiently to permit discussion of the cellular biology of athero­ sclerosis. The opening session was devoted to pathology, macrophages, lipoproteins and their receptors and choles­ terol ester metabolism. Because of the recent emergence of new apolipoprotein technology, a workshop devoted sole­ ly to apolipoprotein methodology was introduced followed by a plenary session devoted to their metabolism and structure. Another rapidly developing area of atherosclerosis research is non-invasive assessment of this condition. Accordingly, a session was devoted to new techniques for this research modality. The final plenary sessions were devoted to the roles of drugs and diet in athero~ scl~rosis - cause, treatment and mechanisms of action. The meeting was summarized by Dr. O.J. Pollak, one of the "founding fathers" of this field. There were nine sessions of proffered papers whose abstracts appear in this volume. In addition, special workshops (to be reported elsewhere) were devoted to several drugs including Oiyzanol, Probucol and Etofibrate.

Keywords

Lipoprotein Nicotin absorption calcium cardiovascular disease clinical trial lipide metabolism pharmacology research

Editors and affiliations

  • David Kritchevsky
    • 1
  • William L. Holmes
    • 2
  • Rodolfo Paoletti
    • 3
  1. 1.The Wistar Institute of Anatomy and BiologyPhiladelphiaUSA
  2. 2.West ChesterUSA
  3. 3.Institute of Pharmacology and PharmacognosyUniversity of MilanMilanItaly

Bibliographic information

Industry Sectors
Pharma
Chemical Manufacturing
Biotechnology
Consumer Packaged Goods